MMP9 and cancer: Results reveal that MMP9 (Fig 2c) and IL-6 (Fig 2d) secretion was significantly upregulated in response to all cancer EVs, relative to untreated cells, while the amount of MMP9 or IL-6 induced was dependent on the cancer cell secreting the EVs.